Nonmelanoma Skin Cancer
News from the FDA/CDC
FDA issues proposed order for over-the-counter sunscreens
“Sprays will be considered for [generally recognized as safe] status so long as properly tested, labeling should be clearer … and bug spray–...
From the Journals
Watchful waiting in BCC: Which patients can benefit?
A study published in JAMA Dermatology sheds light on which patients with BCC may be appropriate candidates for watchful waiting.
From the Journals
New guidance on preventing cutaneous SCC in solid organ transplant patients
Recommendations include cryotherapy as first-line therapy for actinic keratosis, with the exception of thin actinic keratoses grouped in one area...
Case Letter
Verrucous Carcinoma in a Wounded Military Amputee
Verrucous carcinoma is a rare, well-differentiated, locally aggressive squamous cell carcinoma that commonly occurs in sites of inflammation or...
Feature
Medical students lead event addressing disparity in skin cancer morbidity and mortality
The aim of Learn2Derm is to be the first of many that will continue to deliver this type of care to a community that is in need of greater...
From the Journals
Which AK treatment has the best long-term efficacy? A study reviews the data
The analysis “provides data that might contribute to an evidence-based framework to guide the selection of interventions for AK with proven long-...
Commentary
Exploring the Utility of Artificial Intelligence During COVID-19 in Dermatology Practice
Dermatologists should use artificial intelligence as a tool for delivering more efficient and beneficial patient care.
Latest News
Stop using Neutrogena and Aveeno spray sunscreen, J&J warns
Consumers should stop using these products and throw them away, the company said.
From the Journals
Metformin use may curb BCC risk
Population-based study shows a potential protective effect of metformin use for basal cell carcinoma, but no effect on risk of squamous cell...
News
Latest FDA pembrolizumab approval expands label to cutaneous SCCs
The objective response rate in 54 patients with locally advanced disease was 50%, including a complete response rate of 17% and a partial response...
Case Letter
Etanercept-Induced Squamous Proliferations in a Patient With Porokeratosis
The use of biologics, particularly tumor necrosis factor α blockers, rarely are reported to induce skin cancer. Squamous cell carcinoma in the...